Sign in
8-K

Current Report

GYRE THERAPEUTICS, INC. Filed Acc 0001193125-18-012196

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d505387d8k.htm…